Cyclotrons and Radiopharmaceuticals in Positron Emission Tomography

George M. Bohigian, E. Harvey Estes, Ira Friedlander, William R. Kennedy, John H. Moxley, Patricia J. Numann, Paul S. Salva, William C. Scott, Joseph H. Skom, Richard M. Steinhilber, Jack P. Strong, Henry N. Wagner, William R. Hendee, William T. Mcgivney, Joanna S. Fowler, Edward J. Hoffman, Steven M. Larson, Heinrich R. Schelbert, Markus Schwaiger, Henry N. WagnerAlfred P. Wolf, William R. Hendee

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Positron emission tomography (PET) can probe biochemical pathways in vivo and can provide quantitative data; for that purpose, tracers labeled with positron-emitting radioisotopes are essential. This report describes the tracers that are being used or that may have future use, their production by cyclotrons, and other needed resources for PET imaging. Current routine and automated methods for convenient production of labeled compounds, coupled with simple computer-controlled accelerators, can support the creation of clinical PET centers in any large medical institution, obviating the need for in-depth research teams. An alternate approach involves the development of regional centers that provide in-house service and that supply fluorine 18— and carbon 11—labeled compounds to nearby hospitals with PET machines.

Original languageEnglish (US)
Pages (from-to)1854-1860
Number of pages7
JournalJAMA: The Journal of the American Medical Association
Issue number12
StatePublished - Mar 25 1988


Dive into the research topics of 'Cyclotrons and Radiopharmaceuticals in Positron Emission Tomography'. Together they form a unique fingerprint.

Cite this